DexCom, Inc.
DXCM
$73.43
-$0.95-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.20% | 110.85% | 25.30% | -28.01% | -40.81% |
| Total Depreciation and Amortization | 9.93% | 15.01% | 20.92% | 14.29% | 7.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.24% | 1,404.84% | 133.33% | 306.90% | 3.61% |
| Change in Net Operating Assets | -2,459.38% | 1,365.82% | -66.86% | -97.89% | 102.48% |
| Cash from Operations | -2.46% | 230.78% | 8.45% | -12.14% | 125.60% |
| Capital Expenditure | 18.22% | 27.61% | -42.36% | -52.90% | -137.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 328.08% | -14.99% | 124.84% | 42.14% | -138.32% |
| Cash from Investing | 200.95% | -8.32% | 66.33% | 33.96% | -173.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -6.08% | -- | 5.97% | -- |
| Repurchase of Common Stock | -- | 75.04% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.75% | -30.77% | -21.43% | 80.46% | -132.65% |
| Cash from Financing | -95,037.50% | 76.24% | -21.43% | 165.96% | 99.75% |
| Foreign Exchange rate Adjustments | 133.93% | -112.79% | 1,750.00% | 160.53% | -283.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,978.15% | 312.70% | 188.54% | 4.88% | 80.47% |